| 000 | 01687 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513110411.0 | ||
| 264 | 0 | _c19970130 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/(SICI)1097-0215(19961220)69:6<448::AID-IJC5>3.0.CO;2-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChenard, M P | |
| 245 | 0 | 0 |
_aHigh levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cDec 1996 |
||
| 300 |
_a448-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
| 650 | 0 | 4 |
_aCarcinoma _xchemistry |
| 650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xchemistry |
| 650 | 0 | 4 |
_aCarcinoma, Lobular _xchemistry |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aExtracellular Matrix Proteins |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 3 _xanalysis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTamoxifen _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aO'Siorain, L | |
| 700 | 1 | _aShering, S | |
| 700 | 1 | _aRouyer, N | |
| 700 | 1 | _aLutz, Y | |
| 700 | 1 | _aWolf, C | |
| 700 | 1 | _aBasset, P | |
| 700 | 1 | _aBellocq, J P | |
| 700 | 1 | _aDuffy, M J | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 69 _gno. 6 _gp. 448-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1097-0215(19961220)69:6<448::AID-IJC5>3.0.CO;2-4 _zAvailable from publisher's website |
| 999 |
_c8971739 _d8971739 |
||